Aqr Capital Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $1,591 - $3,497	1,501 Added 5.35%	29,558 $32,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $60,322 - $97,918	28,057 New	28,057 $64,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $455,769 - $648,204	-253,205 Reduced 84.34%	47,014 $89,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $582,424 - $1.03 Million	300,219 New	300,219 $721,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $62,456 - $128,251	-47,677 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $139,614 - $278,512	-71,597 Reduced 60.03%	47,677 $100,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $320,363 - $517,963	-84,085 Reduced 41.35%	119,274 $470,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $411,160 - $650,800	-121,645 Reduced 37.43%	203,359 $978,000
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $353,566 - $503,745	85,817 Added 35.88%	325,004 $1.49 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $406,354 - $1.07 Million	117,784 Added 97.02%	239,187 $1.4 Million
Q4 2020 Feb 16, 2021	SELL	$1.05 - $3.67 $547,837 - $1.91 Million	-521,750 Reduced 81.12%	121,403 $415,000
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $809,107 - $1.18 Million	-561,880 Reduced 46.63%	643,153 $926,000
Q2 2020 Aug 17, 2020	SELL	$1.75 - $2.3 $417,205 - $548,326	-238,403 Reduced 16.52%	1,205,033 $2.4 Million
Q1 2020 May 15, 2020	BUY	$1.8 - $4.28 $1.54 Million - $3.66 Million	854,990 Added 145.3%	1,443,436 $2.82 Million
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $1.72 Million - $2.8 Million	544,636 Added 1243.18%	588,446 $2.44 Million
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $52,572 - $291,774	43,810 New	43,810 $132,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $116,184 - $162,685	-13,248 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $161,228 - $215,942	13,248	13,248 $163,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account